Results 1 to 3 of 3

Thread: Frank Reynolds - InVivo will be at W2W Join us to learn more!

  1. #1

    Thumbs up Frank Reynolds - InVivo will be at W2W Join us to learn more!

    Med City News

    0.28.10 InVivo Therapeutics has regenerative answer to spinal cord injury

    InVivo Therapeutics Corp. (OTC:NVIV) closed a reverse merger with its holding company, taking itself public under the stock symbol “NVIV” on the OTC exchange as of tomorrow.

    The Cambridge, Massachusetts-based company also announced a private stock placement that will net it $8.8 million. InVivo is hoping for a nod from the Food & Drug Administration to begin human trials of its regenerative treatment for spinal cord injury.

    The company issued about 31.6 million shares in the reverse merger to stockholders. InVivo issued another 10.5 million units of common stock and warrants in the private placement. Those buyers each received a unit of common stock a five-year warrant exercisable at $1.40 after NVIV stock tops $2.80 per share for 20 days.

    The private placement also included $500,000 in bridge debt conversion, the repayment of the accelerator loan InVivo landed from the Mass. Life Sciences Center last year (earlier this year, Good Start Genetics was the first company to pay back its $500,000 accelerator loan). InVivo said it will also use the proceeds for working capital, R&D and “fixed asset additions.” When it won the accelerator loan in April 2009, Reynolds told MassDevice that the loan would be used to build a manufacturing facility near the UMass-Lowell campus.

    In December 2009, InVivo applied for an investigational device exemption from the Food & Drug Administration to move from primate testing to human trials. Today the company said it expects to begin the trial as soon as it lands FDA approval.

    “Successful treatment options for acute injuries remain elusive. InVivo is pursuing a new paradigm of care, one developed by top scientific minds, that focuses initially on the treatment of secondary injury,” CEO Frank Reynolds said in prepared remarks. “With success in the clinic, we hope to introduce substantial improvements to the treatment of these life-altering injuries within the next two to three years.”

    The InVivo treatment uses a scaffold made of a biodegradable polymer designed to act as a “synthetic extracellular matrix” and to reduce scar formation called astrogliosis. Looking to speed up its trip through the regulatory wilds at the FDA, the company ..... more
    "Our lives begin to end the day
    we become silent about things that matter."
    - Martin Luther King Jr

  2. #2
    I read about this last night. Can't wait to hear more about it.
    Reynolds sounds very motivated and ambitious.

  3. #3
    Quote Originally Posted by Buck_Nastier View Post
    I read about this last night. Can't wait to hear more about it.
    Reynolds sounds very motivated and ambitious.
    He is. I had the pleasure of meeting him a few years ago. Great guy.

Similar Threads

  1. Replies: 23
    Last Post: 02-22-2017, 10:28 PM
  2. about InVivo Therapeutics co.
    By manouli in forum Cure
    Replies: 0
    Last Post: 10-31-2008, 12:15 AM
  3. Replies: 2
    Last Post: 12-22-2002, 12:42 PM
  4. Gerald Reynolds is no friend of the ADA
    By antiquity in forum Life
    Replies: 0
    Last Post: 04-07-2002, 10:37 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •